Product Information
FENOFIBRATE 54 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.0779 per EA under NDC 68180023109. Its NADAC has been published 302 times since Nov 11, 2020.
FDA first approved this application on Aug 17, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Fenofibrate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
54 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180023109
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
FENOFIBRATEApproval Type
Generic (ANDA)
FDA Application
ANDA204019FDA Approved
8/17/2015
TE Code
AB
On Market Since
7/1/2020
Pharmacological Classes
Price Statistics
The NADAC for FENOFIBRATE 54 MG TABLET has been published 302 times since Nov 11, 2020, and over the history we have for it it has declined 65.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0779 per EA |
|---|---|
| All-time high | $0.2281 (Nov 11, 2020) |
| All-time low | $0.0561 (Dec 17, 2025) |
| 52-week high | $0.0900 |
| 52-week low | $0.0561 |
| Median price | $0.0980 |
| Average price | $0.1063 |
| Largest weekly change | -27.7% (Nov 20, 2024) |
| Weeks tracked | 302 |
| Tracking since | Nov 11, 2020 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 19% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FENOFIBRATE 54 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRATE 54 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.0779 per EA (NDC 68180023109), effective Aug 19, 2026.
How has the price of FENOFIBRATE 54 MG TABLET changed over time?
Over the history we have for it, the NADAC for FENOFIBRATE 54 MG TABLET has declined 65.8%. It has been tracked across 302 weekly CMS publications since Nov 11, 2020.
What are the highest and lowest recorded NADAC prices for FENOFIBRATE 54 MG TABLET?
Since Nov 11, 2020, the NADAC for FENOFIBRATE 54 MG TABLET has ranged from a low of $0.0561 (Dec 17, 2025) to a high of $0.2281 (Nov 11, 2020), with a median of $0.0980 per EA.
Are there cheaper alternatives to FENOFIBRATE 54 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FENOFIBRATE 54 MG TABLET, is $0.0630 per EA — about 19% below FENOFIBRATE 54 MG TABLET.
Who manufactures FENOFIBRATE 54 MG TABLET?
FENOFIBRATE 54 MG TABLET (NDC 68180023109) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.